SPRO Spero Therapeutics, Inc.

NASDAQ
$1.23

Spero Therapeutics, Inc. (SPRO) is expected to report earnings on November 11, 2026, after the market close.

Spero Therapeutics Reported Earnings
Wednesday, August 12, 2026 · 4:01 PM ET
Earnings Date
Nov 11
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Spero Therapeutics, Inc.

pero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug-resistant (MDR) bacterial infections and rare diseases.

Sector

Healthcare